Fate Therapeutics (FATE) Prices 6M Common Offering at $5/Share
Tweet Send to a Friend
Fate Therapeutics (NASDAQ: FATE) announced the pricing of an underwritten public offering of 6,000,000 shares of its common stock at ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
